Cargando...

HER2-Positive Breast Cancer: Current Management of Early, Advanced, and Recurrent Disease

PURPOSE OF REVIEW: This review describes the current treatment of human epidermal growth factor receptor-2 (HER2) positive breast cancer with a focus on recently reported clinical trials. Treatment of resistant disease and central nervous system metastases will be reviewed as will new agents that ar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Opin Obstet Gynecol
Autores principales: Callahan, Rena, Hurvitz, Sara
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307801/
https://ncbi.nlm.nih.gov/pubmed/21500375
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!